Review Article
Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
Table 2
Core characteristics of cystic lesions of the pancreas (adapted from [
47]).
| | IPMN | SCN | MCN | SPN | Pseudocysts |
| Mean age (years) | 60–70 | 70 | 40–50 | 30 | 30–50 | Sex | 60–70% male | 90% female | >95% female | 90% female | 70–80% male | Localization (average) | Pancreatic head | Pancreatic tail | Pancreatic body and tail | Pancreatic body and tail | Pancreas ubiquitary | Imaging and MPD | Segmental or diffuse enlargement of the MPD and obligatory communication to the MPD | Microcystic lesion with central scar and calcification (or macrocystic lesion without central scar possible); no connection to the MPD | Macrocystic lesion with septation and calcification of the wall; no connection to the MPD | Mixed solid cystic lesion; no connection to the MPD | Macrocystic lesion without septation; connection to the MPD and probably signs of pancreatitis; enlargement of MPD possible | CEA in cyst | High | Low | High | Low | Low | Mucin production | Yes | No | Yes | No | No | Amylase in cyst | High | Low | Low | Low | High |
|
|
MPD: main pancreatic duct; CEA: carcinoembryonic antigen; IPMN: intraductal papillary mucinous neoplasm; SCN: serous cystic neoplasm; MCN: mucinous cystic neoplasm; SPN: solid pseudopapillary neoplasm.
|